homehealthcare NewsBiocon's Kixelle receives European Commission approval; Kiran Mazumdar Shaw says focused on insulin market
Biocon's Kixelle receives European Commission approval; Kiran Mazumdar Shaw says focused on insulin market
Biocon Biologics a subsidiary of Biocon has announced that Kixelle, a biosimilar insulin Aspart co-developed with Viatris has received marketing authorisation approval from the European Commission.
Biocon Biologics a subsidiary of Biocon has announced that Kixelle, a biosimilar insulin Aspart co-developed with Viatris has received marketing authorisation approval from the European Commission.
Kiran Mazumdar Shaw, Executive Chairperson of Biocon said, “Biocon is focused on being a very strong player in the insulin market globally and this is a very important approval because it adds to our already approved insulin Glargine in the European market and this adds one more insulin to our stable.”
“We expect Aspart approval in the US also not too far ahead, so I think Biocon will have two insulin Analogues in market globally, she added.”
On European market size, Shaw said, “The adjustable market opportunity is a little over a $1 billion certainly there is another biosimilar insulin Aspart of Sanofi which has been approved but we believe this is an expanding market. As we look at global market opportunities it is going to be a sizeable opportunity for Biocon for sure. ”
Watch this video for more
(Edited by : Abhishek Jha)
First Published: Feb 12, 2021 4:03 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024: I.N.D.I.A. bloc to hold rally at Mumbai's BKC today
May 17, 2024 5:18 PM
In Ayodhya, voters talk of a promise fulfilled and yearning for development
May 17, 2024 2:10 PM
Fight of heavyweights in Sambalpur where farmers, weavers hold the key
May 17, 2024 12:25 PM
Odisha: Fight of heavyweights in Sambalpur where farmers, weavers hold the key
May 17, 2024 10:22 AM